Related Experiment Video
Updated: Sep 21, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Can the sum of pooled data from observational studies better evaluate outcome measures for therapies in coronary
Suvitesh Luthra1, David P Taggart2
1a Division of Cardiac Surgery , Derriford Hospital , Plymouth , UK.
Insights
Randomized controlled trials (RCTs) have limitations in evidence-based medicine. Observational studies offer valuable supplements to RCTs, but require rigorous reporting and analysis for clinical practice recommendations.
Area of Science:
- Evidence-based medicine
- Clinical practice guidelines
- Medical research methodology
Background:
- Randomized controlled trials (RCTs) are the established gold standard for medical evidence.
- Clinical practice guidelines rely heavily on the hierarchy of evidence from RCTs.
- Concerns exist regarding the limitations and potential variances of RCTs.
Purpose of the Study:
- To examine the weaknesses inherent in randomized controlled trials.
- To explore discrepancies between large observational studies and RCT results in coronary artery disease.
- To discuss alternative hierarchical systems for clinical recommendations.
Main Methods:
- Analysis of historical coronary artery disease trials.
- Comparison of data from pooled observational studies and RCTs.
- Literature review on evidence-based medicine hierarchies.
Main Results:
- Identified weaknesses and variances in RCTs compared to observational data.
- Demonstrated the potential for observational studies to complement RCT findings.
- Highlighted the need for rigorous guidelines in observational study reporting and analysis.
Conclusions:
- RCTs, while valuable, possess limitations that warrant consideration.
- Observational studies can provide supplementary evidence, necessitating strict methodological standards.
- Alternative evidence hierarchies may offer a more comprehensive basis for clinical recommendations.
Abstract:
Randomized control trials (RCTs) are considered the gold standard in the hierarchy of evidence based medicine. Guidelines and recommendations for clinical practice are based on the strength of evidence in this hierarchical tree. This article looks at the weakness of RCTs and variance between large pooled observational data and trial results for some of the historical trials in coronary artery disease. Observational studies can supplement data from resource intensive RCTs. Guidelines for reporting and analysis however need to be rigorous. It further discusses alternate systems of hierarchies as basis for recommendations.
Related Concept Videos
Observational Studies
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies